# US 2003/0211135 A1 · Stent having electrospun covering and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0211135 A1
- Document ID: US20030211135A1
- Status: Published application
- Kind: A1
- Application number: 10/313,161
- Filed: 2002-12-06
- Published: 2003-11-13
- Earliest claimed: 2002-04-11
- Inventors: Skott E. Greenhalgh; Rob Kiefer; Robert S. Schwartz
- Web page: https://patentgrep.com/patent/US20030211135A1

## CPC

- D01D 5/0084: {Coating by electro-spinning, i.e. the electro-spun fibres are not removed from the collecting device but remain integral with it, e.g. coating of prostheses}
- A61F 2/07: Stent-grafts
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61F 2/89: the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
- A61F 2002/072: {Encapsulated stents, e.g. wire or whole stent embedded in lining}
- A61F 2002/075: {the stent being loosely attached to the graft material, e.g. by stitching}
- Y10T 442/2525: Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]
- D01D: MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A versatile covering process enabled through the identification and manipulation of a plurality of variables present in the electrospinning method of the present invention. By manipulating and controlling various identified variables, it is possible to use electrospinning to predictably produce thin materials having desirable characteristics. The fibers created by the electrospinning process have diameters averaging less than 100 micrometers. Proper manipulation of the identified variables ensures that these fibers are still wet upon contacting a target surface, thereby adhering with each other to form a cloth-like material and, if desired, adhering to the target surface to form a covering thereon. The extremely small size of these fibers, and the resulting interstices therebetween, provides an effective vehicle for drug and radiation delivery, and forms an effective membrane for use in fuel cells.

## Claims

### Claim 1

A method of producing a fibrous covering comprising:
charging a spinneret with an electric potential relative to a predetermined location on a target plate;
placing an object between said spinneret and said predetermined location on said target plate;
forcing a liquid through said spinneret, thereby transferring at least some of said electric potential to said liquid, such that said liquid forms a stream directed toward said predetermined location on said target plate due to the electric potential between said liquid and said predetermined location, and whereby said stream splays into a plurality of nanofibers due to the electric potential between said liquid and said predetermined location, and whereby at least some of said nanofibers collide with said object instead of reaching said target plate;
moving said predetermined location on said target plate relative to said object thereby causing said nanofibers to cover said object.

### Claim 2 (depends on 1)

The method of claim 1 further comprising ensuring that said nanofibers are wet when said nanofibers collide with said object.

### Claim 3 (depends on 2)

The method of claim 2 wherein ensuring that said nanofibers are wet when said nanofibers collide with said object comprises positioning said spinneret a predetermined distance from said object.

### Claim 4 (depends on 2)

The method of claim 2 wherein ensuring that said nanofibers are wet when said nanofibers collide with said object comprises adjusting the air pressure between spinneret and the object to a predetermined pressure.

### Claim 5 (depends on 2)

The method of claim 2 wherein ensuring that said nanofibers are wet when said nanofibers collide with said object comprises adjusting the air temperature between the spinneret and the object to a predetermined temperature.

### Claim 6 (depends on 1)

The method of claim 1 further comprising rotating said object relative to said stream.

### Claim 7 (depends on 1)

The method of claim 1 wherein moving said predetermined location on said target plate relative to said object comprises moving said object over said predetermined location on said target plate.

### Claim 8 (depends on 1)

The method of claim 1 wherein moving said predetermined location on said target plate relative to said object comprises moving said predetermined location on said target plate under said object.

### Claim 9 (depends on 8)

The method of claim 8 further comprising moving said spinneret in concert with said relative movement of said predetermined location on said target plate such that said spinneret remains substantially directly above said predetermined location.

### Claim 10 (depends on 1)

The method of claim 1 wherein placing an object between said spinneret and said predetermined location on said target plate comprises placing a stent between said spinneret and said predetermined location on said target plate.

### Claim 11 (depends on 10)

The method of claim 10 wherein moving said predetermined location on said target plate relative to said object comprises rotating said stent over said predetermined location on said target plate thereby covering the entire stent with nanofibers.

### Claim 12 (depends on 1)

The method of claim 1 wherein forcing a liquid through said spinneret comprises forcing a mixture of a polymer and a solvent through said spinneret.

### Claim 13 (depends on 1)

The method of claim 1 wherein placing an object between said spinneret and said predetermined location on said target plate comprises placing a substrate on said target plate.

### Claim 14 (depends on 13)

The method of claim 13 further comprising removing said covering from said substrate, thus forming a free-standing material of nanofibers.

### Claim 15 (depends on 1)

The method of claim 1 wherein placing an object between said spinneret and said predetermined location on said target plate comprises placing a scrim between said spinneret and said predetermined location on said target plate.

### Claim 16 (depends on 1)

The method of claim 1 further comprising:
charging a second spinneret with an electric potential relative to said predetermined location on said target plate;
forcing a second liquid through said second spinneret, thereby transferring at least some of said electric potential to said liquid, such that said liquid forms a stream directed toward said predetermined location on said target plate due to the electric potential between said liquid and said predetermined location, and whereby said stream splays into a plurality of nanofibers due to the electric potential between said liquid and said predetermined location, and whereby at least some of said nanofibers collide with said object instead of reaching said target plate.

### Claim 17 (depends on 1)

The method of claim 1 further comprising stretching said material, thereby causing said nanofibers to align with each other.

### Claim 18 (depends on 12)

The method of claim 12 wherein forcing a mixture of a polymer and a solvent through said spinneret comprises forcing a mixture of a polymer, belonging to the group PLA, PET, PGA, PCL, PDO, collagen, polytetrafluoroethylene, polyactive, polyurethane, polyester, polypropylene, polyethylene, silicone and PU and a solvent belonging to the group HFIP, dichloromethane, dimethylacetamide, chloroform, dimethylformamide, methylene chloride, and xylene.

### Claim 19 (depends on 1)

The method of claim 1 further comprising texturing said nanofibers.

### Claim 20 (depends on 19)

The method of claim 19 wherein texturing said nanofibers comprises heating said nanofibers and pressing said nanofibers onto a textured surface, thereby transferring the texture of the surface to the nanofibers.

### Claim 21 (depends on 19)

The method of claim 19 wherein texturing said nanofibers comprises using a textured substrate as the object placed between said spinneret and said predetermined location on said target plate, the texture of the substrate thereby transferred to said nanofibers as the nanofibers dry on the textured substrate.

### Claim 22

A method of covering an object with a material, comprising:
charging a spinneret with an electric potential relative to a predetermined location on a target plate;
placing an object to be covered between the spinneret and the target plate;
forcing a liquid through said spinneret, thereby transferring at least some of said electric potential to said liquid, such that said liquid forms a stream directed toward said predetermined location on said target plate due to the electric potential between said liquid and said predetermined location, and whereby said stream splays into a plurality of nanofibers due to the electric potential between said liquid and said predetermined location; and whereby said plurality of nanofibers collide with said object;
ensuring said nanofibers are wet enough to adhere to said object when said nanofibers collide with said object;
placing a material over said object while said nanofibers are still wet, such that said nanofibers bind said material to said object.

### Claim 23 (depends on 22)

The method of claim 22 whereby forcing a liquid through said spinneret comprises forcing a first polymer dissolved in a solvent through said spinneret.

### Claim 24 (depends on 23)

The method of claim 23 wherein placing a material over said object while said nanofibers are still wet comprises placing a material of said first polymer over said object while said nanofibers are still wet.

### Claim 25

A method of bonding a substance to a structure comprising:
providing an electrospinning apparatus;
providing a bonding substance in liquid form;
introducing said bonding substance in liquid form to said electrospinning apparatus;
operating said electrospinning apparatus such that said bonding substance is splayed into nanofibers having an average diameter of less than 100 micrometers;
directing said nanofibers to a target structure;
ensuring said nanofibers remain sufficiently moist as said nanofibers contact said target structure such that said nanofibers form a thin covering on said target structure wherein said covering includes a plurality of randomly located interstitial spaces.

### Claim 26 (depends on 25)

The method of claim 25 wherein providing an electrospinning apparatus comprises:
providing a needle operably connected to a fluid conduit;
providing a pump constructed and arranged to force fluid through said fluid conduit;
providing a target plate operably displaced from said needle; and,
providing a power supply constructed and arranged to establish a variable, controllable electric potential between said target plate and said needle.

### Claim 27 (depends on 25)

The method of claim 25 wherein providing a bonding substance in liquid form comprises providing a mixture of a polymer belonging to the group PLA, PET, PGA, PCL, PDO, collagen, polyactive, polytetrafluoroethylene, polyurethane, polyester, polypropylene, polyethylene, silicone and PU and a solvent belonging to the group HFIP, dichloromethane, dimethylacetamide, chloroform, dimethylformamide, methylene chloride, and xylene.

### Claim 28 (depends on 26)

The method of claim 26 wherein introducing said bonding substance in liquid form to said electrospinning apparatus comprises forcing said bonding substance in liquid form through said fluid conduit.

### Claim 29 (depends on 28)

The method of claim 28 wherein forcing said bonding substance in liquid form through said fluid conduit is accomplished using said pump to force said bonding substance in liquid form through said fluid conduit.

### Claim 30 (depends on 26)

The method of claim 26 wherein operating said electrospinning apparatus such that said bonding substance is splayed into nanofibers having an average diameter of less than 100 micrometers comprises:
positioning said needle 12 inches above said target plate;
controlling said power supply to establish a 19 kV potential between said needle and said plate; and,
energizing and setting said pump to force 0.60 mL/minute of said bonding agent through said fluid conduit.

### Claim 31

A method of delivering a drug to a target site comprising:
charging a spinneret with an electric potential relative to a predetermined location on a target plate;
forcing a liquid containing a drug through said spinneret, thereby transferring at least some of said electric potential to said liquid, such that said liquid forms a stream directed toward said predetermined location on said target plate due to the electric potential between said liquid and said predetermined location, and whereby said stream splays into a plurality of nanofibers due to the electric potential between said liquid and said predetermined location;
ensuring said nanofibers are wet enough to adhere together when said nanofibers collide with said target plate, to form a cloth-like material;
placing said cloth-like material at a target site in vivo, thereby allowing tissue at the target site to elute said drug from said cloth-like material.

### Claim 32 (depends on 31)

The method of claim 31 wherein ensuring said nanofibers are wet enough to adhere together when said nanofibers collide with said target plate, to form a cloth-like material comprises positioning said spinneret a predetermined distance from said target plate.

### Claim 33 (depends on 31)

The method of claim 31 wherein ensuring said nanofibers are wet enough to adhere together when said nanofibers collide with said target plate, to form a cloth-like material comprises adjusting the air pressure between said spinneret and said target plate to a predetermined pressure.

### Claim 34 (depends on 31)

The method of claim 31 wherein ensuring said nanofibers are wet enough to adhere together when said nanofibers collide with said target plate, to form a cloth-like material comprises adjusting the air temperature between said spinneret and said target plate to a predetermined temperature.

### Claim 35 (depends on 31)

The method of claim 31 further comprising:
placing an object between said spinneret and said predetermined location on said target plate, such that at least some of said nanofibers collide with said object instead of reaching said target plate;
moving said predetermined location on said target plate relative to said object thereby causing said nanofibers to cover said object with said cloth-like material.

### Claim 36 (depends on 35)

The method of claim 35 wherein placing an object between said spinneret and said predetermined location on said target plate comprises placing a stent between said spinneret and said predetermined location on said target plate.

### Claim 37 (depends on 35)

The method of claim 35 wherein placing an object between said spinneret and said predetermined location on said target plate comprises placing a scrim between said spinneret and said predetermined location on said target plate.

### Claim 38 (depends on 35)

The method of claim 35 further comprising priming said object with a priming solution prior to placing said object between said spinneret and said predetermined location on said target plate.

### Claim 39 (depends on 38)

The method of claim 38 wherein priming said object comprises dip-coating said object in said liquid.

### Claim 40 (depends on 31)

The method of claim 31 wherein forcing a liquid containing a drug through said spinneret comprises forcing a liquid containing a polymer, a drug and a solvent through said spinneret.

### Claim 41 (depends on 40)

The method of claim 40 wherein forcing a liquid containing a polymer, a drug and a solvent through said spinneret comprises forcing a liquid containing a polymer selected from the group PLA, PET, PGA, PCL, PDO, collagen, polyactive, polytetrafluoroethylene, polyurethane, polyester, polypropylene, polyethylene, silicone and PU, a drug selected from the group rapamycin, taxol and warfin, and a solvent belonging to the group HFIP, dichloromethane, dimethylacetamide, chloroform, dimethylformamide, methylene chloride, and xylene.

### Claim 42 (depends on 41)

The method of claim 41 wherein forcing a liquid containing a polymer, a drug and a solvent through said spinneret comprises forcing a liquid containing PLA at 15-20% by mass, HFIP at 80-85% by mass and a drug selected from the group rapamycin, taxol and warfin at 0.05-1% of the polymer mass.

### Claim 43 (depends on 42)

The method of claim 42 wherein forcing a liquid containing a polymer, a drug and a solvent through said spinneret comprises forcing a liquid containing PLA at 17.9% by mass, HFIP at 82.1% by mass and a drug selected from the group rapamycin, taxol and warfarin at 0.05% of the polymer mass.

### Claim 44 (depends on 41)

The method of claim 41 wherein forcing a liquid containing a polymer, a drug and a solvent through said spinneret comprises forcing a liquid containing a polymer selected from the group PET, PGA, PCL, PDO, collagen, polyactive, polytetrafluoroethylene, polyurethane, polyester, polypropylene, polyethylene, silicone and PU at 10-20% by mass, HFIP at 80-90% by mass and a drug selected from the group rapamycin, taxol and warfin at 0.05-1% of the polymer mass.

### Claim 45 (depends on 31)

The method of claim 31 further comprising rinsing said cloth-like material in a cleaning solution to remove surface drugs prior to placing said cloth-like material at a target site in vivo.

### Claim 46 (depends on 45)

The method of claim 45 wherein rinsing said cloth-like material comprises rinsing said cloth-like material in a cleaning solution selected from the group de-ionized water, CO2, methanol, alcohol, xylene, and sterile water.

### Claim 47 (depends on 31)

The method of claim 31 further comprising:
charging a second spinneret with an electric potential relative to said predetermined location on said target plate;
forcing a second liquid, containing a polymer and a solvent, through said second spinneret, thereby transferring at least some of said electric potential to said liquid, such that said liquid forms a stream directed toward said predetermined location on said target plate due to the electric potential between said liquid and said predetermined location, and whereby said stream splays into a plurality of nanofibers due to the electric potential between said liquid and said predetermined location.

### Claim 48 (depends on 31)

The method of claim 31 wherein placing said cloth-like material at a target site in vivo comprises wrapping said material around an external wall of a blood vessel over an area of the blood vessel where intimal hyperplasia is to be prevented.

### Claim 49 (depends on 31)

The method of claim 31 wherein forcing a liquid containing a drug through said spinneret, thereby transferring at least some of said electric potential to said liquid, such that said liquid forms a stream directed toward said predetermined location on said target plate due to the electric potential between said liquid and said predetermined location, and whereby said stream splays into a plurality of nanofibers due to the electric potential between said liquid and said predetermined location comprises forcing a liquid containing an immunosuppressant through said spinneret, thereby transferring at least some of said electric potential to said liquid, such that said liquid forms a stream directed toward said predetermined location on said target plate due to the electric potential between said liquid and said predetermined location, and whereby said stream splays into a plurality of nanofibers due to the electric potential between said liquid and said predetermined location

### Claim 50

A material comprising a plurality of randomly-oriented inter-tangled, non-woven fibrils of a first polymer having an average diameter of less than 100 micrometers.

### Claim 51 (depends on 50)

The material of claim 50 wherein said fibrils comprise a drug.

### Claim 52 (depends on 51)

The material of claim 51 wherein said drug is an immunosuppressant.

### Claim 53 (depends on 52)

The material of claim 52 wherein said drug belongs to the group rapamycin, taxol and warfin.

### Claim 54 (depends on 50)

The material of claim 50 further comprising a drug trapped within interstices between and defined by said fibrils.

### Claim 55 (depends on 50)

The material of claim 50 further comprising a plurality of drug-containing microspheres, each microsphere trapped within an interstice between and defined by said fibrils.

### Claim 56 (depends on 50)

The material of claim 50 wherein said material further comprises a plurality of randomly-oriented inter-tangled, non-woven fibrils of a second polymer having an average diameter of less than 100 micrometers.

### Claim 57 (depends on 50)

The material of claim 50 wherein said fibrils comprise perfluorosulfonate ionomer.

### Claim 58 (depends on 50)

The material of claim 50 further comprising a scrim operably attached to said randomly-oriented inter-tangled, non-woven fibrils of a first polymer, such that said scrim is covered by said fibrils on at least one side of said scrim.

### Claim 59 (depends on 50)

The material of claim 50 wherein said fibrils further comprise an isotope.

### Claim 60 (depends on 59)

The material of claim 59 wherein said isotope comprises 169thulium oxide.

### Claim 61 (depends on 59)

The material of claim 59 wherein said isotope comprises 45calcium chloride.

### Claim 62 (depends on 50)

The material of claim 50 wherein said polymer has a viscosity of between 1 and 50 centipoise when in liquid form.

### Claim 63

A method of delivering radiation to a target site comprising:
charging a spinneret with an electric potential relative to a predetermined location on a target plate;
forcing a liquid containing an isotope through said spinneret, thereby transferring at least some of said electric potential to said liquid, such that said liquid forms a stream directed toward said predetermined location on said target plate due to the electric potential between said liquid and said predetermined location, and whereby said stream splays into a plurality of nanofibers due to the electric potential between said liquid and said predetermined location;
positioning said spinneret a predetermined distance from said target plate such that said nanofibers are wet enough to adhere together when said nanofibers collide with said target plate, to form a cloth-like material;
placing said cloth-like material at a target site in vivo;
directing electromagnetic energy toward said cloth-like material.

### Claim 64 (depends on 63)

The method of claim 63 wherein directing electromagnetic energy toward said cloth-like material occurs before placing said cloth-like material at a target site in vivo.

### Claim 65 (depends on 63)

The method of claim 63 wherein directing electromagnetic energy toward said cloth-like material occurs after placing said cloth-like material at a target site in vivo.

### Claim 66 (depends on 64)

The method of claim 64 wherein directing electromagnetic energy toward said cloth-like material comprises placing said cloth-like material in a nuclear reactor for a predetermined period at a predetermined power level.

### Claim 67 (depends on 66)

The method of claim 66 wherein placing said cloth-like material in a nuclear reactor for a predetermined period at a predetermined power level comprises placing said cloth-like material in a nuclear reactor for between 30 and 60 minutes at a power level of between 1 and 10 megawatts.

### Claim 68 (depends on 67)

The method of claim 67 wherein placing said cloth-like material in a nuclear reactor for a predetermined period at a predetermined power level comprises placing said cloth-like material in a nuclear reactor for between 40 and 50 minutes at a power level of between 3 and 7 megawatts.

### Claim 69 (depends on 67)

The method of claim 67 wherein placing said cloth-like material in a nuclear reactor for a predetermined period at a predetermined power level comprises placing said cloth-like material in a nuclear reactor for approximately 42 minutes at a power level of approximately 5 megawatts.

### Claim 70

A covering for a stent comprising:
a plurality of fibrils, of a first polymer, the fibrils having diameters that average less than 100 micrometers, the fibrils adhered to an outside surface of said stent, the fibrils intertangled with each other but not woven;
a drug, operably contained within the covering.

### Claim 71 (depends on 70)

The stent covering of claim 70 wherein said drug is dissolved within said fibrils.

### Claim 72 (depends on 70)

The stent covering of claim 70 wherein said drug is contained in liquid form within interstices defined by and located between said fibrils;

### Claim 73 (depends on 70)

The stent covering of claim 70 wherein said drug is contained in microsphere form within interstices defined by and located between said fibrils.

### Claim 74

A stent comprising:
a body lumen support structure;
a covering disposed on said support structure;
said covering comprised of a plurality of fibrils having an average diameter less than 100 micrometers;
said fibrils arranged in a substantially random pattern on said support structure so as to create a plurality of substantially random interstitial spaces within said covering; and,
a therapeutic agent disposed within said covering.

### Claim 75 (depends on 74)

A stent according to claim 74, wherein said therapeutic agent is a drug.

### Claim 76 (depends on 74)

A stent according to claim 74, wherein said therapeutic agent belongs to the group, growth factor and cytokine.

### Claim 77 (depends on 74)

A stent according to claim 74, wherein said therapeutic agent is living cells.

### Claim 78 (depends on 74)

A stent according to claim 74, wherein said therapeutic agent is an anti-restenosis agent.

### Claim 79 (depends on 74)

A stent according to claim 74, wherein said therapeutic agent is disposed within said interstitial spaces.

### Claim 80 (depends on 74)

A stent according to claim 74, wherein at least a portion of said fibrils contain said therapeutic agent.

### Claim 81 (depends on 74)

A stent according to claim 74, wherein said fibrils are comprised of a polymer.

### Claim 82 (depends on 74)

A stent according to claim 74, wherein said fibrils are comprised of a polymer and a therapeutic agent.

### Claim 83

A structure for maintaining the patency of a body lumen comprising:
a supporting scaffold;
a covering applied to said scaffold;
said covering comprising a plurality of nanofibers applied to said scaffold in a substantially wet state so as to maximize adherence of said nanofibers to one another and to said scaffold;
said nanofibers having an average diameter less than about 100 micrometers;
a plurality of interstitial spaces in said covering formed by said nanofibers.

### Claim 84 (depends on 83)

A structure according to claim 83, further comprising a tissue treatment substance disposed in at least a portion of said interstitial spaces.

### Claim 85 (depends on 84)

A structure according to claim 84, wherein said tissue treatment substance is an anti-restenosis drug.

### Claim 86 (depends on 83)

A structure according to claim 83, wherein said nanofibers are comprised of a polymer.

### Claim 87 (depends on 83)

A structure according to claim 83, wherein said nanofibers are comprised of a polymer and a tissue treatment substance.

### Claim 88

A method of maintaining the patency of a body lumen comprising:
providing a stent frame;
covering said stent frame with wet fibrils, said fibrils having a diameter less than 100 micrometers in diameter;
allowing said wet fibrils to adhere to one another and to said stent frame so as to create a covering having a plurality of substantially randomly placed interstitial spaces;
loading said covering with a therapeutic agent;
introducing said sent frame into a body lumen;
allowing said therapeutic agent to affect tissue in said body lumen.

### Claim 89 (depends on 88)

A method according to claim 88, wherein the loading of said covering with a therapeutic agent includes covering said stent frame with fibrils comprised of a polymer and said therapeutic agent.

### Claim 90 (depends on 88)

A method according to claim 88, wherein the loading of said covering with a therapeutic agent includes filling at least a portion of said interstitial spaces with said therapeutic agent.

### Claim 91 (depends on 88)

A method according to claim 88, wherein the allowing of said therapeutic agent to affect tissue includes allowing the elution of a drug into said tissue.

### Claim 92 (depends on 91)

A method according to claim 91, wherein the elution includes elution of an anti-restenosis drug.

### Claim 93 (depends on 88)

A method according to claim 88, wherein the covering of said stent frame is performed using electrospinning.

### Claim 94 (depends on 88)

A method according to claim 88, wherein allowing said therapeutic agent to affect tissue in said body lumen comprises expanding said stent until said stent contacts said tissue in said body lumen.

### Claim 95 (depends on 94)

A method according to claim 94, wherein expanding said stent causes said fibrils to align circumferentially, thereby increasing the radial strength of said covering.

### Claim 96

A method of controlling the drug release rate of an implantable drug-containing object comprising covering the object with a fibrous fabric having interstices defined between the fibers that are small enough to control the rate at which a drug contained by the object may elute into tissue surrounding the object when the object is implanted.

### Claim 97 (depends on 96)

The method of claim 96 wherein covering the object with a fibrous fabric having interstices defined between the fibers that are small enough to control the rate at which a drug contained by the object may elute into tissue surrounding the object when the object is implanted comprises covering the object with a polymer fabric having a plurality of fibrils having diameters that average less than 100 micrometers.

### Claim 98 (depends on 96)

The method of claim 96 wherein covering the object with a fibrous fabric having interstices defined between the fibers that are small enough to control the rate at which a drug contained by the object may elute into tissue surrounding the object when the object is implanted comprises covering the object with a polymer fabric having a plurality of fibrils that are intertangled with each other but not woven.

### Claim 99

A drug-eluting cloth comprising:
an inner layer of fibers of a first average diameter and defining interstices between the fibers;
a therapeutic releasably contained by the inner layer;
an outer layer of fibers of a second average diameter and defining interstices between said fibers that are smaller than the interstices of the inner layer such that the release rate of the therapeutic is controlled by the interstices of the outer layer;
wherein the outer layer is operably attached to and substantially encasing the inner layer.

### Claim 100 (depends on 99)

The drug-eluting cloth of claim 99 wherein the fibers of the outer layer comprise electrospun fibrils having an average diameter of less than 100 micrometers.

### Claim 101 (depends on 99)

The drug-eluting cloth of claim 99 wherein the fibers of the inner and outer layers comprise electrospun fibrils.

### Claim 102 (depends on 101)

The drug-eluting cloth of claim 101 wherein the first average diameter is greater than the second average diameter.

### Claim 103 (depends on 99)

A drug eluding cloth of claim 99 wherein the outer layer comprises a first polymer and the inner layer comprises a second polymer different than the first polymer.

### Claim 104 (depends on 99)

The drug-eluting cloth of claim 99 wherein the therapeutic releasably contained by the inner layer is disposed in at least a portion of the interstices of the inner layer.

### Claim 105 (depends on 99)

The drug-eluting cloth of claim 99 wherein the therapeutic releasably contained by the inner layer is encased in a plurality of microspheres, which are disposed in at least a portion of the interstices of the inner layer.

### Claim 106

A method of coating an object comprising:
covering the object with a layer of fibers defining interstices between the fibers;
treating the covered object until at least a portion of the interstices are reduced.

### Claim 107 (depends on 106)

The method of claim 106 wherein covering the object with a layer of fibers defining interstices between the fibers comprises electrospinning a polymer onto the object.

### Claim 108 (depends on 106)

The method of claim 106 wherein covering the object with a layer of fibers defining interstices between the fibers comprises covering a stent with a layer of fibers defining interstices between the fibers, the stent defining spaces, the layer of fibers including bridge portions that span over the spaces.

### Claim 109 (depends on 106)

The method of claim 106 wherein treating the covered object until at least a portion of the interstices are reduced comprises heating the covered object to a predetermined temperature until at least a portion of the interstices are reduced.

### Claim 110 (depends on 109)

The method of claim 109 wherein heating the covered object to a predetermined temperature until at least a portion of the interstices are reduced comprises heating the covered stent to a predetermined temperature for a predetermined time until the bridge portions of the layers of fibers collapse and bond to the stent.

### Claim 111 (depends on 109)

The method of claim 109 wherein heating the covered object to a predetermined temperature until at least a portion of the interstices are reduced comprises heating the covered object to a predetermined temperature until substantially all of the interstices are reduced.

### Claim 112 (depends on 109)

The method of claim 109 wherein heating the covered object to a predetermined temperature until at least a portion of the interstices are reduced comprises heating the covered object to a predetermined temperature until the fibers melt, thereby substantially eliminating all of the interstices.

### Claim 113 (depends on 106)

The method of claim 106 wherein treating the covered object until at least a portion of the interstices are reduced comprises exposing the covered object to a solvent gas atmosphere until at least a portion of the interstices are reduced.

### Claim 114

A structure for maintaining the patency of a body lumen comprising:
a scaffolding structure having a side wall defining at least one space;
a fibrous coating attached to at least a portion of the scaffolding structure but not spanning the at least one space of the side wall.

### Claim 115 (depends on 114)

The structure of claim 114 wherein said scaffolding structure comprises a braided wire stent.

### Claim 116 (depends on 114)

The structure of claim 114 wherein said scaffolding structure comprises a non-braided stent.
